E-viri
Recenzirano
Odprti dostop
-
Rabi, Doreen M., MD, MSc; Daskalopoulou, Stella S., MD, PhD; Padwal, Raj S., MD, MSc; Khan, Nadia A., MD, MSc; Grover, Steven A., MD, MPA; Hackam, Daniel G., MD, PhD; Myers, Martin G., MD; McKay, Donald W., PhD; Quinn, Robert R., MD, PhD; Hemmelgarn, Brenda R., MD, PhD; Cloutier, Lyne, RN, PhD; Bolli, Peter, MD; Hill, Michael D., MD, MSc; Wilson, Thomas, MD; Penner, Brian, MD; Burgess, Ellen, MD; Lamarre-Cliché, Maxime, MD; McLean, Donna, RN, MN, NP, PhD(c); Schiffrin, Ernesto L., MD, PhD; Honos, George, MD; Mann, Karen, MSc, PhD; Tremblay, Guy, MD; Milot, Alain, MD, MSc; Chockalingam, Arun, MS, PhD; Rabkin, Simon W., MD; Dawes, Martin, MBBS, MD(Lond); Touyz, Rhian M., MD, PhD; Burns, Kevin D., MD; Ruzicka, Marcel, MD, PhD; Campbell, Norman R.C., MD; Vallée, Michel, MD, PhD; Prasad, G.V. Ramesh, MBBS, MSc; Lebel, Marcel, MD; Campbell, Tavis S., PhD; Lindsay, M. Patrice, BScN, PhD; Herman, Robert J., MD; Larochelle, Pierre, MD; Feldman, Ross D., MD; Arnold, J. Malcolm O., MD; Moe, Gordon W., MD, MSc; Howlett, Jonathan G., MD; Trudeau, Luc, MD; Bacon, Simon L., PhD; Petrella, Robert J., MD, PhD; Lewanczuk, Richard, MD; Stone, James A., MD, PhD; Drouin, Denis, MD; Boulanger, Jean-Martin, MD; Sharma, Mukul, MD, MSc; Hamet, Pavel, MD, PhD; Fodor, George, MD, PhD; Dresser, George K., MD, PhD; Carruthers, S. George, MD; Pylypchuk, George, MD; Gilbert, Richard E., MD, PhD; Leiter, Lawrence A., MD; Jones, Charlotte, MD, PhD; Ogilvie, Richard I., MD; Woo, Vincent, MD; McFarlane, Philip A., MD, PhD; Hegele, Robert A., MD; Poirier, Luc, BPharm, MSc; Tobe, Sheldon W., MD
Canadian journal of cardiology, 07/2011, Letnik: 27, Številka: 4Journal Article
Abstract We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2011. The major guideline changes this year are: (1) a recommendation was made for using comparative risk analogies when communicating a patient's cardiovascular risk; (2) diagnostic testing issues for renal artery stenosis were discussed; (3) recommendations were added for the management of hypertension during the acute phase of stroke; (4) people with hypertension and diabetes are now considered high risk for cardiovascular events if they have elevated urinary albumin excretion, overt kidney disease, cardiovascular disease, or the presence of other cardiovascular risk factors; (5) the combination of an angiotensin-converting enzyme (ACE) inhibitor and a dihydropyridine calcium channel blocker (CCB) is preferred over the combination of an ACE inhibitor and a thiazide diuretic in persons with diabetes and hypertension; and (6) a recommendation was made to coordinate with pharmacists to improve antihypertensive medication adherence. We also discussed the recent analyses that examined the association between angiotensin II receptor blockers (ARBs) and cancer.
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.